Optos PLC of Dunfermline, UK, has received FDA approval for its P200MA retinal imaging device. The instrument, which takes a quarter of a second to scan approximately 80 percent of the retina, is expected to aid in the detection of glaucoma, diabetes and high blood pressure, among other diseases. The technology is already being tested in the US.